Literature DB >> 25218620

Effects of chronic administration of fenproporex on cognitive and non-cognitive behaviors.

Cinara L Gonçalves1, Camila B Furlanetto, Samira S Valvassori, Daniela V Bavaresco, Roger B Varela, Josiane Budni, João Quevedo, Emilio L Streck.   

Abstract

Fenproporex (Fen) is an amphetamine-based anorectic; amphetamine use causes a broad range of severe cognitive deficits and anxiogenic-like effects. In this study we evaluated pharmacological effects of the chronic administration of Fen on cognitive and non-cognitive behaviors. Male adult Wistar rats received intraperitoneal administration of vehicle (control group) or Fen (6.25, 12.5 or 25 mg/kg) for 14 days; the animals were then subjected to habituation and object recognition tasks in open-field apparatus, and elevated plus-maze task. The administration of Fen (12.5 and 25 mg/kg) impaired habituation during the second exposure to the habituation task. In addition, the same doses of Fen also impaired the performance in object recognition task. In elevated plus-maze task, the administration of Fen (in all doses tested) induced anxiogenic-like effects in rats. Our results suggest that chronic Fen administration alters memory and induces anxiogenic-like effects in rats.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25218620     DOI: 10.1007/s11011-014-9617-1

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  36 in total

1.  Cognitive performance of current methamphetamine and cocaine abusers.

Authors:  Sara L Simon; Catherine P Domier; Tiffanie Sim; Kimberly Richardson; Richard A Rawson; Walter Ling
Journal:  J Addict Dis       Date:  2002

Review 2.  A review of the clinical pharmacology of methamphetamine.

Authors:  Christopher C Cruickshank; Kyle R Dyer
Journal:  Addiction       Date:  2009-04-29       Impact factor: 6.526

3.  Neuropsychological function and delay discounting in methamphetamine-dependent individuals.

Authors:  William F Hoffman; Meredith Moore; Raymond Templin; Bentson McFarland; Robert J Hitzemann; Suzanne H Mitchell
Journal:  Psychopharmacology (Berl)       Date:  2006-08-17       Impact factor: 4.530

4.  Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Kevin P Conway; Wilson Compton; Frederick S Stinson; Bridget F Grant
Journal:  J Clin Psychiatry       Date:  2006-02       Impact factor: 4.384

5.  Impaired object recognition memory following methamphetamine, but not p-chloroamphetamine- or d-amphetamine-induced neurotoxicity.

Authors:  Annabelle M Belcher; Steven J O'Dell; John F Marshall
Journal:  Neuropsychopharmacology       Date:  2005-11       Impact factor: 7.853

6.  Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat.

Authors:  S Pellow; P Chopin; S E File; M Briley
Journal:  J Neurosci Methods       Date:  1985-08       Impact factor: 2.390

7.  Influence of chronic amphetamine treatment and acute withdrawal on serotonin synthesis and clearance mechanisms in the rat ventral hippocampus.

Authors:  Jeffrey L Barr; Jamie L Scholl; Rajeshwari R Solanki; Michael J Watt; Christopher A Lowry; Kenneth J Renner; Gina L Forster
Journal:  Eur J Neurosci       Date:  2012-11-14       Impact factor: 3.386

8.  Imported fenproporex-based diet pills from Brazil: a report of two cases.

Authors:  Pieter A Cohen
Journal:  J Gen Intern Med       Date:  2009-03       Impact factor: 5.128

9.  The effect of relapse on cognition in abstinent methamphetamine abusers.

Authors:  Sara L Simon; Jennifer Dacey; Susan Glynn; Richard Rawson; Walter Ling
Journal:  J Subst Abuse Treat       Date:  2004-07

10.  Executive functions among individuals with methamphetamine or alcohol as drugs of choice: preliminary observations.

Authors:  Raul Gonzalez; Antoine Bechara; Eileen M Martin
Journal:  J Clin Exp Neuropsychol       Date:  2007-02       Impact factor: 2.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.